resiquimod has been researched along with 1,2-dioleoyl-sn-glycero-3-phosphoglycerol in 1 studies
| Studies (resiquimod) | Trials (resiquimod) | Recent Studies (post-2010) (resiquimod) | Studies (1,2-dioleoyl-sn-glycero-3-phosphoglycerol) | Trials (1,2-dioleoyl-sn-glycero-3-phosphoglycerol) | Recent Studies (post-2010) (1,2-dioleoyl-sn-glycero-3-phosphoglycerol) |
|---|---|---|---|---|---|
| 465 | 14 | 318 | 308 | 0 | 122 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bollag, WB; Chen, X; Choudhary, V; Griffith, S | 1 |
1 other study(ies) available for resiquimod and 1,2-dioleoyl-sn-glycero-3-phosphoglycerol
| Article | Year |
|---|---|
Pathogen-Associated Molecular Pattern-Induced TLR2 and TLR4 Activation Increases Keratinocyte Production of Inflammatory Mediators and is Inhibited by Phosphatidylglycerol.
Topics: Animals; Calgranulin B; Glycine max; Humans; Imidazoles; Inflammation Mediators; Keratinocytes; Lipopeptides; Lipopolysaccharides; Macrophages; Mice; NF-kappa B; Pathogen-Associated Molecular Pattern Molecules; Phosphatidylglycerols; RAW 264.7 Cells; Receptors, Pattern Recognition; Recombinant Proteins; Toll-Like Receptor 2; Toll-Like Receptor 4 | 2020 |